PRESS DIGEST- Financial Times - May 29
May 29 The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.
Dec 16 Aptevo Therapeutics Inc :
* "latest data show combination of Otlertuzumab and bendamustine is well tolerated"
* Aptevo - exploring utility of otlertuzumab in combination with additional CLL therapies to evaluate clinical benefit in distinct CLL patient subgroup
* Aptevo Therapeutics announces publication of phase 2 clinical data for otlertuzumab Source text for Eikon: Further company coverage:
May 29 London's Heathrow Airport said early on Monday that there were still some disruptions to British Airways flights from the airport following a global computer system failure at the airline.